Combo Device Strategies: Pathways to Market

On September 18, Bill Geary will be speaking on a panel at the "Combo Drug & Device Strategies: Pathways to Market" event presented by M2D2 and MDG Boston. This engaging event brings together key voices from the healthcare and life sciences sectors. The panel discussion will delve into the complexities and strategic considerations involved in bringing combination drug-device products to market.

In addition to the expert panel, there will be live pitches from trailblazing companies developing next-generation combination products. These innovators will showcase their technologies and share firsthand experiences navigating the complex journey from concept to commercialization - including securing investment, overcoming regulatory challenges, and positioning their products for market success.